Trials / Enrolling By Invitation
Enrolling By InvitationNCT03527342
Sahlgrenska Cardiomyopathy Project
Sahlgrenska University Hospital Cardiomyopathy Project: Mapping and Diagnosis of Cardiomyopathies to Enable Early and Specific Treatment
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (estimated)
- Sponsor
- Göteborg University · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
This is a joint project by Sahlgrenska University Hospital: Sahlgrenska, Östra and Mölndal. Our objective is to diagnose and map patients with well phenotyped cardiomyopathies (CMP) including in depth clinical and molecular phenotyping to enable earlier and specific treatment. The project will serve as: 1. resource for diagnostic and therapeutic trials 2. common biomaterial bank 3. resource for detailed molecular analyses on patients' biomaterials and patient specific symptoms and examination results
Conditions
- Dilated Cardiomyopathies
- Hypertrophic Cardiomyopathy
- Restrictive Cardiomyopathy
- Arrhythmogenic Right Ventricular Cardiomyopathy
- Myocarditis
- Sarcoidosis With Myocarditis
- Giant Cell Myocarditis
- Amyloidosis; Heart (Manifestation)
Timeline
- Start date
- 2018-06-01
- Primary completion
- 2028-01-01
- Completion
- 2029-01-01
- First posted
- 2018-05-17
- Last updated
- 2018-11-06
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT03527342. Inclusion in this directory is not an endorsement.